MiR-181a-2-3p as a potential diagnostic and prognostic marker for myelodysplastic syndrome-Reference-Cited by-同舟云学术

MiR-181a-2-3p as a potential diagnostic and prognostic marker for myelodysplastic syndrome

Published:2022-11-29 Issue:1 Volume:27 Page:1246-1252
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Liang Xiaolin¹²,Shi Zeyan¹²,Huang Xiaoke¹,Wan Chengyao¹,Zhu Shanhu¹,Wu Meiqing¹,Li Zhongqing¹,Tang Zhongyuan¹,Li Jing¹²,Zhao Weihua¹²,Luo Jun¹²,Liu Zhenfang¹²

Affiliation:

1. Hematology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People’s Republic of China

2. Key Laboratory of Hematology, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, Guangxi, People’s Republic of China

Funder

National Natural Science Foundation of China

Science Research and Technology Development Project of Qingxiu District of Nanning

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2022.2149971

Reference32 articles.

1. Myelodysplastic Syndromes

2. Molecular mechanisms involved in the progression of myelodysplastic syndrome

3. The role of microRNA in myelodysplastic syndromes: beyond DNA methylation and histone modification

4. Time-dependent changes in mortality and transformation risk in MDS

5. Clinical and biological implications of driver mutations in myelodysplastic syndromes

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA dysregulation in myelodysplastic syndromes: implications for diagnosis, prognosis, and therapeutic response;Frontiers in Oncology;2024-08-02

2. The Role of Non-Coding RNAs in Myelodysplastic Neoplasms;Cancers;2023-09-30